Venous thromboembolism during pregnancy

American Family Physician

Volumn 77, Issue 12, 2008, Pages 1709-1716

  Dresang, Lee T ^a   Fontaine, Pat ^b   Leeman, Larry ^c   King, Valerie J ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; D DIMER; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN; WARFARIN; ANTICOAGULANT AGENT;

ALLERGIC REACTION; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; BRAIN MALFORMATION; BREAST FEEDING; CLINICAL TRIAL; COMPRESSION GARMENT; COMPRESSION THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; DELIVERY; DOPPLER ECHOGRAPHY; DRUG HALF LIFE; DYSPNEA; ECHOGRAPHY; EDEMA; EMBOLECTOMY; EMBRYOPATHY; FAMILY HISTORY; FETAL HEMORRHAGE; GENE MUTATION; GESTATIONAL EDEMA; HIGH RISK POPULATION; HUMAN; LEG PHLEBOGRAPHY; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; POSTTHROMBOSIS SYNDROME; PREGNANCY; PUERPERIUM; REVIEW; RISK FACTOR; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH; TACHYPNEA; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT CONTRAINDICATION; VENOUS THROMBOEMBOLISM; ALGORITHM; DRUG CONTRAINDICATION; FEMALE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; VEIN THROMBOSIS;

ALGORITHMS; ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS;

EID: 47749106835     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Snow V, Qaseem A, Barry P, et al., for the American College of Physicians, American Academy of Family Physicians Panel on Deep Venous Thrombosis/Pulmonary Embolism. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2007;146(3):204-210.
2. Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance - United States, 1991-1999. MMWR Surveill Summ. 2003;52(2):1-8.
3. Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline [published correction appears in Ann Intern Med. 2007;146(5):396] Ann Intern Med. 2007;146(3):211-222.
4. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697-706. (Pubitemid 41692527)
5. Zotz RB, Gerhardt A, Scharf RE. Prediction, prevention and treatment of venous thromboembolic disease in pregnancy. Semin Thromb Hemost. 2003;29(2):143-154. (Pubitemid 36458193)
6. Nelson-Piercy C. Thromboprophylaxis during pregnancy, labour and after vaginal delivery. Royal College of Obstetricians and Gynaecologists, 2004. Guideline no. 37. http://www.rcog.org.uk/resources/Public/pdf/ Thromboprophylaxis-no037.pdf. Accessed February 23, 2008.
7. Blanco-Molina A, Trujillo-Santos J, Criado J, et al., for the RIETE Investigators. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost. 2007;97(2):186-190. (Pubitemid 46592137)
8. Deneux-Tharaux C, Carmona E, Bouvier-Colle MH, Breart G. Postpartum maternal mortality and cesarean delivery. Obstet Gynecol. 2006;108(3 pt 1):541-548. (Pubitemid 44337094)
9. Robertson L, Wu O, Langhorne P, et al., for the Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132(2):171-196.
10. American College of Obstetricians and Gynecologists. Thromboembolism in pregnancy. ACOG Practice Bulletin No. 19. Obstet Gynecol. 2000;96(2):1-10.
11. Faught W, Garner P, Jones G, Ivey B. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol. 1995;172(1 pt 1):147-150.
12. Greer IA, Thomson AJ. Thromboembolic disease in pregnancy and the puerperium: acute management. Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists, 2007. Guideline no. 28. http://www.rcog.org.uk/resources/Public/pdf/green-top-28-thromboembolic- minorrevision.pdf. Accessed February 23, 2008.
13. Gerhardt A, Scharf RE, Zotz RB. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb Haemost. 2003;90(1):77-85. (Pubitemid 36873862)
14. Friederich PW, Sanson BJ, Simioni P, et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis [published corrections appear in Ann Intern Med. 1997;127(12):1138, and Ann Intern Med. 1997;126(10):835]. Ann Intern Med. 1996;125(12):955-960. (Pubitemid 27209663)
15. American College of Obstetricians and Gynecologists. Antiphospholipid syndrome: ACOG Practice Bulletin No. 68. Obstet Gynecol. 2005;106(5 pt 1):1113-1121.
16. Gherman RB, Goodwin TM, Leung B, Byrne JD, Hethumumi R, Montoro M. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol. 1999;94(5 pt 1):730-734. (Pubitemid 29484440)
17. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 2001;119(1 suppl):122S-131S. (Pubitemid 32154198)
18. Urbano FL. Homans' sign in the diagnosis of deep venous thrombosis. Hosp Physician. March 2001:22-24. http://www.jcomjournal.com/pdf/hp-mar01-homan.pdf. Accessed February 23, 2008. (Pubitemid 33247301)
19. Qaseem A, Snow V, Barry P, et al., for the Joint American Academy of Family Physicians/American College of Physicians Panel on Deep Venous Thrombosis/Pulmonary Embolism. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med. 2007;146(6):454-458.
20. Michiels JJ, Freyburger G, van der Graaf F, Janssen M, Oortwijn W, Van Beek E. Strategies for the safe and effective exclusion and diagnosis of deep vein thrombosis by the sequential use of clinical score, D-dimer testing, and compression ultrasonography. Semin Thromb Hemost. 2000;26(6):657-667. (Pubitemid 32009605)
21. Morse M. Establishing a normal range for d-dimer levels through pregnancy to aid in the diagnosis of pulmonary embolism and deep vein thrombosis. J Thromb Haemost. 2004;2(7):1202-1204. (Pubitemid 40186100)
22. Francalanci I, Comeglio P, Alessandrello Liotta A, et al. D-dimer plasma levels during normal pregnancy measured by specific ELISA. Int J Clin Lab Res. 1997;27(1):65-67. (Pubitemid 27284724)
23. Kanne JP, Lalani TA. Role of computed tomography and magnetic resonance imaging for deep venous thrombosis and pulmonary embolism. Circulation. 2004;109(12 suppl 1):115-121. (Pubitemid 38419162)
24. Krivak TC, Zorn KK. Venous thromboembolism in obstetrics and gynecology. Obstet Gynecol. 2007;109(3):761-777. (Pubitemid 46339419)
25. Roy PM, Colombet I, Durieux P, Chatellier G, Sors H, Meyer G. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ. 2005;331(7511):259. (Pubitemid 41097908)
26. Matthews S. Short communication: imaging pulmonary embolism in pregnancy: what is the most appropriate imaging protocol? Br J Radiol. 2006;79(941):441-444. (Pubitemid 43676350)
27. Quiroz R, Kucher N, Zou KH, et al. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA. 2005;293(16):2012-2017. (Pubitemid 40570895)
28. Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med. 2006;119(12):1001-1002. (Pubitemid 44826939)
29. Winer-Muram HT, Boone JM, Brown HL, Jennings SG, Mabie WC, Lombardo GT. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology. 2002;224(2):487-492. (Pubitemid 34809132)
30. Doyle NM, Ramirez MM, Mastrobattista JM, Monga M, Wagner LK, Gardner MO. Diagnosis of pulmonary embolism: a cost-effectiveness analysis. Am J Obstet Gynecol. 2004;191(3):1019-1023. (Pubitemid 39298152)
31. Chan WS, Ray JG, Murray S, Coady GE, Coates G, Ginsberg JS. Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med. 2002;162(10):1170-1175. (Pubitemid 34522406)
32. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):627S-644S. (Pubitemid 39297966)
33. Pillny M, Sandmann W, Luther B, et al. Deep venous thrombosis during pregnancy and after delivery: indications for and results of thrombectomy. J Vasc Surg. 2003;37(3):528-532. (Pubitemid 36350894)
34. Dong B, Jirong Y, Liu G, Wang Q, Wu T. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. 2006;(2):CD004437.
35. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401-407. (Pubitemid 40981229)
36. van Dongen CJ, van den Belt AA, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev. 2004;(4):CD001100.
37. Richter C, Sitzmann J, Lang P, Weitzel H, Huch A, Huch R. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol. 2001;52(6):708-710. (Pubitemid 34015632)
38. Schulman S, Rhedin AS, Lindmarker P,Carlsson A, Lärfars G, Nicol P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med. 1995;332(25):1661-1665.
39. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [published correction appears in Chest. 2005;127(1):416]. Chest. 2004;126(3 suppl):401S-428S.
40. Schulman S, Granquist S, Holström M, et al. The duration of oral anticoagulant therapy after a second episode of thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1997;336(6):393-398.
41. Ramin SM, Ramin KD, Gilstrap LC. Anticoagulants and thrombolytics during pregnancy. Semin Perinatol. 1997;21(2):149-153.
42. Gates S, Brocklehurst P, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2002;(2):CD001689.
43. Kent N, Leduc L, Crane J, et al. Prevention and treatment of venous thromboembolism (VTE) in obstetrics. J SOGC. 2000;22(9):736-749.
44. Jacobsen AF, Drolsum A, Klow NE, Dahl GF, Qvigstad E, Sandset PM. Deep vein thrombosis after elective cesarean section. Thromb Res. 2004;113(5):283-288. (Pubitemid 38737368)
45. Quiñones JN, James DN, Stamilio DM, Cleary KL, Macones GA. Thromboprophylaxis after cesarean delivery: a decision analysis. Obstet Gynecol. 2005;106(4):733-740. (Pubitemid 41362176)
46. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2000;(3): CD001484.
47. Casele H, Grobman WA. Cost-effectiveness of thromboprophylaxis with intermittent pneumatic compression at cesarean delivery. Obstet Gynecol. 2006;108(3 pt 1):535-540. (Pubitemid 44337093)